The Kumamoto Insulin Degludec Observational (KIDUNA) Study

The Kumamoto Insulin Degludec Observational (KIDUNA) Study - KIDUNA Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037963

Enrollment

500

Registered

2019-09-09

Start date

2013-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 and type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult Japanese outpatients with T1D or T2D treated with the basal-bolus insulin therapy (BBT) using rapid-acting insulin analogue and long-acting insulin analogue

Exclusion criteria

Exclusion criteria: The exclusion criteria were pregnant or nursing women and subjects in whom the physician deemed IDeg treatment inappropriate.

Design outcomes

Primary

Measure	Time frame
changes in HbA1c from baseline at 3, 6 and 12 months	—

Countries

Japan

Contacts

Public ContactSeiya Shimoda

Kumamoto university Faculty of Life Sciences

sshimoda@gpo.kumamoto-u.ac.jp096-373-5169

Outcome results